Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
AstraZeneca
Merck
Accenture
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald
Argus Health
US Army

Generated: October 19, 2017

DrugPatentWatch Database Preview

COLISTIMETHATE SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Colistimethate Sodium, and what generic Colistimethate Sodium alternatives are available?

Colistimethate Sodium is a drug marketed by X Gen Pharms, Xellia Pharms Aps, Emcure Pharms Ltd, Fresenius Kabi Usa, Sagent Pharms, and Paddock Llc. and is included in six NDAs.

The generic ingredient in COLISTIMETHATE SODIUM is colistimethate sodium. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.

Summary for Tradename: COLISTIMETHATE SODIUM

US Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list6
Clinical Trials: see list2,411
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COLISTIMETHATE SODIUM at DailyMed

Pharmacology for Tradename: COLISTIMETHATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X Gen Pharms
COLISTIMETHATE SODIUM
colistimethate sodium
INJECTABLE;INJECTION064216-001Feb 26, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
COLISTIMETHATE SODIUM
colistimethate sodium
INJECTABLE;INJECTION065364-001Apr 17, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Xellia Pharms Aps
COLISTIMETHATE SODIUM
colistimethate sodium
INJECTABLE;INJECTION205356-001May 29, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Emcure Pharms Ltd
COLISTIMETHATE SODIUM
colistimethate sodium
INJECTABLE;INJECTION202359-001Sep 28, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
COLISTIMETHATE SODIUM
colistimethate sodium
INJECTABLE;INJECTION065177-001Mar 19, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
COLISTIMETHATE SODIUM
colistimethate sodium
INJECTABLE;INJECTION201365-001Feb 19, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Dow
McKesson
McKinsey
Johnson and Johnson
Federal Trade Commission
UBS
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot